Findings

What do systematic reviews say?

17 questions · 17 findings · 6 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 11 · 64.7%GRADE not reported 1 · 5.9%Very low 0 · 0%Low 2 · 11.8%Moderate 3 · 17.6%High 0 · 0%

Minoxidil vs placebo

Change in quality of life · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 260 participants
Low

Finasteride vs placebo

Change in quality of life ‐ not measured · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Fexofenadine 120 mg/d vs placebo (1‐week intervention)

Secondary outcome: quality of life · adults with eczema

The review found no eligible studies for this question.

1 finding from 1 review

Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Loratadine 10 mg vs placebo (4‐week intervention)

Secondary outcome: quality of life · adults with eczema

The review found no eligible studies for this question.

1 finding from 1 review

Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Loratadine 10 mg vs placebo (2‐week intervention)

Secondary outcome: quality of life · adults with eczema

The review found no eligible studies for this question.

1 finding from 1 review

Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cetirizine 0.5 mg/kg/d vs placebo (18‐month intervention)

Secondary outcome: quality of life · children with eczema

The review found no eligible studies for this question.

1 finding from 1 review

Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cetirizine 10 mg/d vs placebo (4‐week intervention)

Secondary outcome: quality of life · adults with eczema

The review found no eligible studies for this question.

1 finding from 1 review

Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Moisturisers vs vehicle, placebo or no moisturiser

Change from baseline in health‐related quality of life · people with eczema

1 finding from 1 review

Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 300 participants
Low

Spironolactone 100 mg vs placebo

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Finasteride 5 mg to 7.5 mg vs placebo

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin 500 mg to 2550 mg per day vs placebo

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Flutamide 250 mg b.i.d. vs placebo

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Urea‐containing moisturisers vs vehicle, placebo or no moisturiser

Change from baseline in health‐related quality of life ‐ not measured · people with eczema

The review found no eligible studies for this question.

1 finding from 1 review

Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Glycerin/glycerol‐containing moisturisers vs vehicle or placebo

Change from baseline in health‐related quality of life ‐ not measured · people with eczema

The review found no eligible studies for this question.

1 finding from 1 review

Emollients and moisturisers for eczema 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Bleach bath vs placebo or bath emollient

Change from baseline in quality of life CDLQI ranges from 0 to 30 with higher values indicating more impaired quality of life. · people with atopic dermatitis

1 finding from 1 review

Interventions to reduce Staphylococcus aureus in the management of eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Moderate

Oral antibiotics vs placebo

Change from baseline in quality of life IDQoL ranges from 0 to 30 with higher values indicating more impaired quality of life. · people with atopic dermatitis

1 finding from 1 review

Interventions to reduce Staphylococcus aureus in the management of eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 45 participants
Moderate

CDLQI Scores range from 0 to 30. Lower scores indicate better health‐related quality of life. Calculations are based on the change from baseline to week 12 in both groups · people with paediatric psoriasis

1 finding from 1 review

Anti‐TNF agents for paediatric psoriasis 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 211 participants
Moderate